Literature DB >> 3277808

Persistent pulmonary hypertension in the neonate.

E D Graves1, C R Redmond, R M Arensman.   

Abstract

Respiratory failure is the leading cause of death in the neonatal period. The anatomic and functional basis for this, particularly in full-term infants, most often is persistent pulmonary hypertension of the neonate (PPHN). This condition is reversible but can cause very severe and unrelenting respiratory failure and ultimate death when uncontrolled. Recent technologic advances have expanded the scope of therapy available for PPHN, resulting in increasing therapeutic success for these critically ill infants. This article reviews the anatomic and functional anomalies of PPHN, as well as the methods of diagnosis and discusses current treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277808     DOI: 10.1378/chest.93.3.638

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Antidepressant use in pregnant and postpartum women.

Authors:  Kimberly A Yonkers; Katherine A Blackwell; Janis Glover; Ariadna Forray
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

2.  Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size.

Authors:  Beena G Sood; Jennifer Peterson; Monica Malian; Robert Galli; Maria Geisor-Walter; Jon McKinnon; Jody Sharp; Krishna Rao Maddipati
Journal:  Pharmacol Res       Date:  2007-10-02       Impact factor: 7.658

3.  Effect of blood pressure cuffs on neonatal circulation: their potential application to newborns with persistent pulmonary hypertension.

Authors:  J Rhodes; J T Wung; F Z Bierman
Journal:  Pediatr Cardiol       Date:  1995 Jan-Feb       Impact factor: 1.655

4.  Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs.

Authors:  Beena G Sood; Elizabeth J Dawe; Krishna Rao Maddipati; Monica Malian; Xinguang Chen; Robert Galli; Raja Rabah
Journal:  Pulm Pharmacol Ther       Date:  2008-02-06       Impact factor: 3.410

5.  Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.

Authors:  Marc Chester; Pierre Tourneux; Greg Seedorf; Theresa R Grover; Jason Gien; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

Review 6.  Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.

Authors:  Megan Galbally; Salvatore Gentile; Andrew J Lewis
Journal:  CNS Drugs       Date:  2012-10-01       Impact factor: 6.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.